title: Niacin: Time to Believe Outcomes Over Surrogate Outcomes: If Not Now, When?
authors.affiliation: From the Section of Cardiovascular Medicine and the Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, CT; Department of Health Policy and Management, Yale School of Public Health, New Haven, CT; and Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, CT. harlan.krumholz@yale.edu.
authors.forename: Harlan M
authors.initials: HM
authors.lastname: Krumholz
mesh_terms: D008076:Cholesterol, HDL; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009203:Myocardial Infarction; D009525:Niacin / Q000627:therapeutic use*
chemical_list: D008076:Cholesterol, HDL; D000960:Hypolipidemic Agents; D009525:Niacin
keywords: United States; lipid; myocardial infarction; niacin; risk factor